MDL Archives - Carey Danis & Lowe

Over 700 IVC Filter Lawsuits Pending in Federal Court

By | IVC Filters, Uncategorized

inferior vena cavaAs of July 2016, there are over 700 Inferior Vena Cava (IVC) filter lawsuits pending in a federal court in Arizona. The multidistrict litigation (MDL) is IN RE: Bard IVC Filters Products Liability Litigation, MDL No. 2641.

The US Food and Drug Administration (FDA) issued a warning on IVC filters after receiving hundreds of adverse event reports. According to the FDA’s warning from May 2014, the adverse event reports “include device migration, filter fracture, embolization (movement of the entire filter or fracture fragments to the heart or lungs), perforation of the IVC, and difficulty removing the device.”

IVC Filter Study

Carey Danis & Lowe attorneys described an IVC filter study conducted by the Yale School of Medicine, and published in March 2016 in the Journal of the American College of Cardiology. Ultimately, the researchers concluded that IVC filter benefits are still unclear.

IVC Filter Lawsuits

Did you suffer an IVC filter injury? If you did, we encourage you to explore your legal options with one of our attorneys. Carey Danis & Lowe offers free, no obligation case evaluations. Call our law firm today — 1-800-721-2519. You can also reach us online through our confidential personal injury claim form.

2700 Testosterone Gel Lawsuits in US

By | Pharmaceutical litigation, Testosterone, Uncategorized

testoserone_gelOver 2,700 testosterone gel lawsuits are pending in the US. According to a Forbes article from late October 2015, testosterone lawsuits numbered around 2,000 in August 2015. In the ensuing months, even more men who suffered serious testosterone side effects stepped forward, bringing the total near 3,000.

A legal representative commented in the Forbes article that the lawsuits are “not quite to the halfway point in terms of the number of suits we’re going to see.”

Lawsuits consolidated in Chicago

Testosterone lawsuits are consolidated in a multidistrict litigation (MDL) in Chicago. The MDL cites 7 companies that make testosterone products.

The US District Court Judge managing the MDL, Judge Matthew Kennelly, is moving pretrial proceedings along at an efficient pace. In late 2016, the court will begin the bellwether trial process; at this time, rulings will be made on bellwether testosterone lawsuits that both parties carefully selected as representative of a majority of the MDL lawsuits.

AbbVie and AndroGel

This first round of bellwether cases scheduled for 2016 involves AbbVie and their testosterone product, AndroGel.

These AndroGel lawsuits allege that AbbVie’s testosterone product caused blood clots, heart attacks, and strokes. These lawsuits also argue that AbbVie’s AndroGel marketing campaigns misled them to believe the product as safe.

Decline in AndroGel sales

According to the Forbes article cited above, AndroGel sales plummeted as testosterone lawsuits rose. AndroGel sales dropped by 32% in the first 6 months of 2015.


Carey Danis & Lowe AndroGel lawyers represent men just like you who have been injured by testosterone gel, including Abbvie’s AndroGel. Our team of experienced testosterone lawyers are investigating cases, and encourage you to explore your legal options with us today.

For a free case evaluation, call us toll free at 800.721.2519.

You can also reach us online by completing a confidential personal injury claim form.

Boston Scientific Delays, Vaginal Mesh Lawsuits Return to State Courts

By | Defective Medical Device litigation, Transvaginal Mesh, Uncategorized

boston_scientifi_transvaginal_mesh_lawsuitIn late October 2015, a federal judge denied a request made by Boston Scientific, a manufacturer of vaginal mesh devices. The company sought to move 62 transvaginal mesh lawsuits, which were filed as a single multi-plaintiff suit, into a multidistrict litigation (MDL).

An MDL concerning transvaginal mesh injuries and Boston Scientific mesh products exists in a West Virginia federal court. The MDL is In re: Boston Scientific Corp., Pelvic Repair System Products Liability Litigation, MDL No. 2326, managed by Judge Joseph R. Goodwin in the U.S. District Court for the Southern District of West Virginia in Charleston.

The federal judge who denied Boston Scientific’s request stated that the company waited too long to move the lawsuits from state to federal court. In California, U.S. District Judge Beverly Reid O’Connell said that Boston Scientific should’ve issued their request within a year of the lawsuit’s original file date.

Since they waited too long, a state court judge has since separated the individual mesh lawsuits, and sent them back to courts in their state of origin.

This is an unfortunate turn of events for these plaintiffs. Consolidation into the MDL would bring them all one step closer to putting this difficult chapter in their lives behind them.

You don’t have to suffer alone.

We are here to help you. If you or a loved one suffered from a transvaginal mesh injury, we encourage you to explore your legal options.

Carey Danis & Lowe offers free case evaluations, during which we can discuss your compensation eligibility, and whether filing a vaginal mesh lawsuit is right for you.

Call Carey Danis & Lowe today ― 800.721.2519.

You can also reach us online by completing a confidential personal injury claim form.


You may be interested in reading…

Zofran Multidistrict Litigation (MDL) Formed in Massachusetts

By | Pharmaceutical litigation, Uncategorized, Zofran

zofran-birth-defectsThe Judicial Panel on Multidistrict Litigation (JPML) ordered to consolidate Zofran birth defect lawsuits in Massachusetts.

Why did the JPML consolidate Zofran cases?

An increasing number of families across the US are coming forward, seeking to hold Zofran’s manufacturer, GlaxoSmithKline (GSK), accountable.

And accounting for the current number of pending Zofran lawsuits, in addition to estimates of future lawsuits, the move to consolidate is wise.

What is an MDL?

Think of a multidistrict litigation like this.

Say you ask 10 small grocers across the US for 10 red apples. And the small grocers hop to it, and each of them meets your request.

In doing so, they’re duplicating the same action, over and over again.

This duplicative process is what MDLs seek to avoid. When similar lawsuits are consolidated, there’s no replicating the same legal process over and over; put another way, grocers don’t have to pick out those 10 red apples over and over again.

Another benefit of MDLs is they avoid the confusion of conflicting rulings that can happen when cases are tried separately in courts all over the US.

Zofran MDL

On October 13, 2015, the JPML consolidated Zofran lawsuits into MDL No. 2657 before Judge Dennis F. Saylor IV.

GlaxoSmithKline has been here before

In 2012, GSK pled guilty to criminal charges brought by the US Department of Justice (DOJ). The charges alleged that GSK “promoted certain forms of Zofran, approved only for post-operative nausea, for the treatment of morning sickness in pregnant women”.

GSK and the DOJ agreed to a civil settlement in excess of $1 billion.

GSK also pled guilty to “promoting…Zofran for off-label, non-covered use and paying kickbacks to physicians”.

Do you want to hold GSK accountable?

If so, we can help you.

The team of experienced Zofran lawyers at Carey Danis & Lowe are available to discuss your case with you during a free case evaluation.

We can walk you through your legal options and compensation eligibility.

Call Carey Danis & Lowe today at 800.721.219. You can also reach us by completing a confidential personal injury claim form.

GMO Corn Seed Lawsuits on the Rise

By | Class Action, Consumer protection, GMO, Uncategorized

gI_118526_cdl-pr-122014-gmo-corn-seed-lawsuitsMore and more GMO corn seed lawsuits are being filed in the multidistrict litigation (MDL) in Kansas. In one month, the lawsuits targeting the biotech giant, Syngenta, climbed from 300 to almost 1,800. The big increase in GMO corn lawsuits indicates that U.S. corn farmers want to hold Syngenta accountable for their handling of the GMO corn seed, Agrisure Viptera.

These lawsuits assert that Syngenta sold GMO corn seeds that were disapproved by a major U.S. trading partner―China. These U.S. corn farmers were set up for failure, planting, growing and harvesting a crop for which there was no buyer.

According to a court document, Syngenta received warnings from corn industry insiders. These warnings expressed concern about Syngenta selling Agrisure Viptera to U.S. corn farmers without first seeking approval from China.

The corn industry insiders warned that there could be serious economic repercussions for U.S. corn farmers if Syngenta began selling Agrisure Viptera.

Clearly, Syngenta ignored these warnings.

Our corn lawyers can help you recover losses.

Carey Danis & Lowe is a law firm with headquarters in St. Louis. Our corn lawyers understand how so many Midwestern towns depend upon a successful corn growing season. That is why our law firm works tirelessly to recover losses for U.S. corn farmers.

Contact Carey Danis & Lowe for a free case evaluation. One of our corn lawyers can discuss your case, analyze your compensation eligibility, and if applicable, guide you through the process of filing a GMO corn seed lawsuit.

You can reach Carey Danis & Lowe by phone at 800.721.2519, or by completing a confidential personal injury claim form.

Family Creates Nonprofit to Publicize Hazards of NuvaRing

By | Defective Medical Device litigation, NuvaRing, Pharmaceutical litigation, Uncategorized

nuvaringThe Langhart parents were expecting their daughter, Erika, to fly home for Thanksgiving. Instead, they got a call summoning them to a Virginia hospital, because their daughter had suffered multiple heart attacks. By the time they got to the Virginal Hospital Center, she was in a coma.

The doctor asked whether Erika was using birth control. Upon learning that Erika used NuvaRing, the doctor stated that “there’s a link between NuvaRing and pulmonary embolisms.” The doctors removed the contraceptive device immediately, but it was too late. A blood clot that started in her thigh caused extensive pulmonary embolisms, many episodes of cardiac arrest and eventual brain death.

The Langharts didn’t know that NuvaRing had been linked to other women’s deaths. NuvaRing’s manufacturer Merck admits that there’s a very small risk of blood clots, but maintains that there’s evidence to support the safety and efficacy of the NuvaRing.

Despite this claim, Merck settled a multidistrict litigation (MDL) for $100 million, because Organon, the original maker of the NuvaRing , “failed to adequately warn consumers about a heightened risk of blood clots associated with the use of NuvaRing, even though the manufacturer was aware that NuvaRing posed greater risks than other hormonal contraceptives.”

The Langharts, however, didn’t settle. They want Merck held accountable for failure to properly warn women of the risk. To further their mission, they created a nonprofit honoring their daughter. Using her name, they called the organization “Informed Choice for Amerika”, working with the mission of advising women about the hazards related to NuvaRing and the relative risks of hormonal contraceptives.

Unfortunately, the use of NuvaRing is widespread: it’s one of the most popular birth control products on the market.

Carey Danis & Lowe Can Help

The trusted attorneys at Carey Danis and Lowe work tirelessly to help victims who have been injured by defective medical products.

If you or your loved one is suffering from the ill effects of NuvaRing, please give us a call at 800-721-2519 or send us an email. Carey Danis & Lowe works with a group of nurses and medical experts to address your medical concerns. Our initial consultations are free of charge.

A June Meeting for Consolidated Vaginal Mesh Lawsuits

By | Defective Medical Device litigation, Transvaginal Mesh, Uncategorized

Boston Scientific Ordered to Release Defective Transvaginal Mesh DocumentsBoston Scientific Ordered to Release Defective Transvaginal Mesh DocumentsWhen Judge Goodwin said he was going to “kick it into high gear”, he really meant it.

According to a pretrial order (PTO) filed in early April 2015, Judge Joseph R. Goodwin scheduled a status conference for 6 of 7 transvaginal mesh multidistrict litigations (MDLs) being heard in the U.S. District Court for the Southern District of West Virginia.

Representatives for plaintiffs and defendants will meet on June 2, 2015.

In the PTO, the court scheduled each MDL for about an hour-long meeting. The meeting schedule for June 2 is as follows:

  • 10:00 am – C.R. Bard MDL 2187
  • 11:00 am – Boston Scientific MDL 2326
  • 1:30 pm – Ethicon MDL 2327
  • 2:30 pm – Coloplast MDL 2387
  • 3:00 pm – Cook MDL 2440

The transvaginal mesh lawyers at Carey Danis & Lowe are pleased to see Judge Goodwin’s drive to keep each of these MDLs on track.

We Can Help You

Carey Danis & Lowe currently represents women who’ve been injured by transvaginal mesh products manufactured by C.R. Bard, Boston Scientific, Ethicon, Coloplast, and Cook.

If you have suffered from any serious transvaginal mesh side effects, such as chronic pain or mesh erosion, we encourage you to begin exploring your legal options.

Free Case Evaluations

During your free case evaluation, one of our defective medical device lawyers will guide you through your legal options, compensation eligibility, and if applicable, the process of filing a vaginal mesh lawsuit.


Upcoming Meetings in Testosterone Litigation in Illinois

By | Pharmaceutical litigation, Testosterone, Uncategorized

testosterone gel lawsuitPretrial proceedings are going smoothly in the testosterone multidistrict litigation (MDL) that is being held in an Illinois federal court. The testosterone MDL is scheduled to meet three times this spring, with the next meeting scheduled for March 20, 2015.

The U.S. District Court for the Northern District of Illinois has also scheduled case management conferences on April 21 and on May 19.

The MDL currently has 1,247 pending testosterone lawsuits.

The plaintiffs involved in the MDL are men who have been injured by testosterone products, including testosterone gel, such as Androgel, a product manufactured by AbbVie.

Studies have shown that testosterone use in older male patients who are using the hormone to treat signs of male aging, such as decreased muscle mass, energy, and libido, have an increased risk of cardiovascular complications, including heart attack or stroke.

On March 3, 2015, the U.S. Food and Drug Administration (FDA) released a statement ordering manufacturers of testosterone products to update their labeling to include information on cardiovascular risks. The FDA also noted in their statement that the agency has not yet approved the use of testosterone to treat male aging, and has only approved these kinds of products to treat patients with medical conditions that cause low testosterone levels.

Legal Help for Men Injured by Testosterone Gels

Carey Danis & Lowe is a national law firm with headquarters in St. Louis that specializes in defective drug litigation. Our dedicated team of personal injury lawyers are currently representing men in testosterone gel lawsuits. If you or someone you love has suffered from a testosterone injury, contact our law offices for a free, no obligation case evaluation.

Carey Danis & Lowe is here is here to listen to you. Call our law firm at 800.721.2519, or complete a confidential personal injury claim form.

We look forward to offering you any legal and/or medical assistance that we can.

Continue to read the Carey Danis & Lowe law blog, and stay current on testosterone lawsuit news. You might be interested in reading:

FDA Warns about Using Testosterone for Aging

Testosterone Gel & Its Risks


Yaz & Yasmin Lawsuits to Be Remanded

By | Pharmaceutical litigation, Uncategorized, Yaz/Yasmin

yaz_lawsuit_yasmin_side_effects_lawsuits_dvt_blood_clot_settlementsSettling Yaz and Yasmin lawsuits in the Yaz and Yasmin multidistrict litigation (MDL) is a slow process, a fact recently expressed by the federal judge managing the MDL. It appears that the cause of the slow process is Bayer’s legal strategy, which U.S. District Judge David R. Herndon likened to attrition.

In a document filed in mid-February 2015, Judge Herndon described Bayer’s approach to settlement as either an effort to wear down the other parties, or an expectation that “an entire group of catastrophically injured women, for the most part, [will] simply drop their claims”.

In order to more quickly settle these Yaz and Yasmin lawsuits, of which there are 3,400 still pending, the court will request on or around July 1 that the Judicial Panel on Multidistrict Litigation (JPML) remand a group of cases to their home districts for trial.

In addition to remanding certain lawsuits, the court rescheduled the trial of a case involving the plaintiff, Pamela Schuchert, to start on June 15. According to a court document, the Schuchert trial will have a 10-day limit.

Legal Assistance for Yaz, Yasmin & Ocella Victims

Carey Danis & Lowe represents Yaz, Yasmin, and Ocella victims. For more information about our legal services, contact our law offices by phone at 800.721.2519.

800 GMO Corn Lawsuits from 20 States

By | Consumer protection, GMO, Product Liability, Uncategorized

gmocornseedlawsuitU.S. corn growers are taking a stand against biotechnology companies by filing GMO corn lawsuits. There are approximately 800 pending lawsuits from 20 states. In late January, a judicial panel ruled to consolidate a portion of these lawsuits into a multidistrict litigation (MDL) under the management of Judge John Lungstrum in a U.S. District Court in Kansas.

The farmers behind these 800 GMO corn lawsuits claim to have suffered financial losses somewhere between $1 – $2.9 billion.

According to Arkansas Business, farmers growing non-GMO corn have also suffered financially as a result of cross-pollination.

These GMO corn seed lawsuits concern a genetically-modified corn seed developed by a Swiss biotechnology company, Syngenta. The GMO corn seed is Agrisure Viptera, or MIR 162.

Though China now accepts imports of corn products grown by using Agrisure Viptera seeds, this was not always the case. A major trade partner, China’s refusal of Agrisure Viptera corn products caused substantial financial damage to U.S. corn growers.

Losses from GMO Corn?

If you suffered losses from GMO corn, we can help. Carey Danis & Lowe is a St. Louis-based law firm that currently represents farmers in GMO corn lawsuits in Missouri and other corn-growing states. Our dedicated team of attorneys work diligently to recover losses for clients.

We encourage you to begin exploring your legal options and compensation eligibility today. Carey Danis & Lowe offers free, no obligation case evaluations. Find out if you should file a GMO corn lawsuit.

Contact Carey Danis & Lowe today by calling 800.721.2519, or by completing a confidential claim form.